Production capacity adjustments in the Fine Chemicals Division
First written in FY2019-Q1. 6 of 21 entries say "Advanced", first in FY2023. Latest entry: FY2026-H1.
No other company in this theme has enough history to compare yet.
- FY2026-H1AdvancedAnnual report
「Fine Chemicals segment 1,244 109.1」
Production output in the Fine Chemicals segment during the current interim consolidated accounting period was ¥1,244 million, or 109.1% of the same period of the previous year, with the recovery in production output continuing. - FY2025RestatedAnnual report
「Sales of products for some domestic markets in the Fine Chemicals segment were recovering as the COVID-19 pandemic subsided, but sales were ¥2,150 million due to the impact of the sales mix.」
The company continued to report a recovery trend in domestic sales, but segment sales were ¥2,150 million due to the impact of the sales mix. - FY2025-H1RestatedAnnual report
「Sales of products for some domestic markets in the Fine Chemicals segment were recovering as the COVID-19 pandemic subsided, but sales were ¥1,130 million due to the impact of the sales mix.」
While domestic product sales showed signs of recovery as economic and social activity normalized, sales for the interim period were ¥1,130 million due to the impact of the sales mix. - FY2024AdvancedAnnual report
「During the fiscal year, production output in the Fine Chemicals segment increased significantly from the previous fiscal year. The main factor was higher sales volume.」
Production output in the Fine Chemicals segment was ¥2,338 million, or 124.7% of the previous fiscal year, with the production recovery advancing on a full-year basis against a backdrop of higher sales volume. - FY2024-Q3AdvancedAnnual report
「During the third quarter cumulative period, production output in the Fine Chemicals segment increased significantly from the same cumulative period of the previous year. The main factor was higher sales volume.」
Production output in the Fine Chemicals segment was ¥1,771 million, or 125.2% of the same quarter of the previous year, with the production recovery advancing against a backdrop of higher sales volume. - FY2024-Q2AdvancedAnnual report
「During the second quarter cumulative period, production output in the Fine Chemicals segment increased significantly from the same quarter of the previous year. The main factors were an increase in production volume resulting from higher sales volume, among others.」
Production output in the Fine Chemicals segment was ¥1,320 million, or 123.5% of the same quarter of the previous year, with the increase continuing against a backdrop of recovering domestic sales. - FY2024-Q1AdvancedAnnual report
「During the first quarter cumulative period, production output in the Fine Chemicals segment increased significantly from the previous year. The main factors were an increase in production volume resulting from higher sales volume, among others.」
Production output in the Fine Chemicals segment was ¥660 million, or 151.8% of the same quarter of the previous year, indicating progress in the production recovery against a backdrop of higher sales volume. - FY2023AdvancedAnnual report
「Sales in the Fine Chemicals segment were ¥2,110 million, up 13.3% from the previous fiscal year, as domestic product sales recovered with the normalization of economic and social activity.」
The recovery in domestic sales was confirmed on a full-year basis, with Fine Chemicals segment sales increasing 13.3% from the previous fiscal year. - FY2023-Q3Continued growth in production outputAnnual report
「Fine Chemicals segment 1,414 114.7」
Production output in the Fine Chemicals segment during the third quarter cumulative period was ¥1,414 million, or 114.7% of the same quarter of the previous year, marking continued growth in production output. - FY2023-Q2Continued growth in production outputAnnual report
「During the second quarter cumulative period, production output in the Saccharification Products, Fine Chemicals and By-products segments increased significantly from the previous year. The main factors were an increase in production volume resulting from higher sales volume, among others.」
Production output in the Fine Chemicals segment was ¥1,069 million, or 121.3% of the same quarter of the previous year, with the production recovery continuing against a backdrop of normalized economic and social activity and higher sales volume. - FY2023-Q1Sales recovery as economic and social activity normalizesAnnual report
「(Fine Chemicals segment) Sales of products for the domestic market in the Fine Chemicals segment also recovered gradually as economic and social activity normalized. As a result, sales increased by ¥100 million, or 23.9%, from the same quarter of the previous year to ¥540 million.」
The trend changed from the decline in domestic demand for pharmaceutical applications that had continued through the previous fiscal year to a recovery in domestic product sales as economic and social activity normalized. - FY2022Maintaining flat sales through price optimization despite lower sales volumeAnnual report
「In the Fine Chemicals segment, sales volume declined from the previous fiscal year due to weaker domestic demand for pharmaceutical applications resulting from the renewed spread of COVID-19. However, sales were ¥1,860 million, unchanged from the previous fiscal year, as the company advanced product price optimization in response to soaring raw corn and fuel costs.」
While sales volume continued to decline due to domestic demand for pharmaceutical applications, product price optimization kept segment sales at the same level as the previous fiscal year. - FY2022-Q3RestatedAnnual report
「In the Fine Chemicals segment, sales of products for pharmaceutical applications in Japan also recovered gradually as economic and social activity normalized, despite the impact of the renewed spread of COVID-19. As a result, sales were ¥1,390 million, compared with ¥1,410 million in the same quarter of the previous year.」
The Fine Chemicals segment continued to report sales below the same quarter of the previous year due to weaker domestic demand for pharmaceutical applications. - FY2022-Q2RestatedAnnual report
「Production output in the Fine Chemicals segment decreased from the previous year, compared with ¥1,102 million in the same quarter of the previous year. The main factors were a decline in production volume associated with lower sales volume of products for pharmaceutical applications, due to the spread of COVID-19, among others.」
The Fine Chemicals segment continued to experience lower production output due to declining sales volume of products for pharmaceutical applications. - FY2022-Q1Reversal to declining production outputAnnual report
「During the first quarter cumulative period, production output in the Fine Chemicals segment decreased from the previous year, compared with ¥529 million in the same quarter of the previous year. The main factors were a decline in production volume resulting from lower sales volume, among others.」
The trend changed from the recovery in production output following the previous fiscal year's facility renovations, and production output in the Fine Chemicals segment declined in the first quarter due to lower sales volume. - FY2021Continued growth in production outputAnnual report
「Fine Chemicals segment 1,981 107.5」
The Fine Chemicals segment's production output for the fiscal year was ¥1,981 million, or 107.5% of the previous fiscal year, indicating a continued recovery from the decline associated with facility renovations in the previous fiscal year. - FY2021-Q1Higher production output driven by increased sales volumeAnnual report
「During the first quarter cumulative period, production output in the Fine Chemicals segment increased significantly from the previous year. The main factors were an increase in production volume resulting from higher sales volume, among others.」
Following the recovery from the process shutdown associated with production facility renovations in the previous fiscal year, increased sales volume was cited as a factor behind higher Fine Chemicals segment production output this quarter. Production output was ¥529 million, or 130.9% of the same quarter of the previous year. - FY2020Full-year production output recoveryAnnual report
「Fine Chemicals segment 1,843 121.8」
The Fine Chemicals segment's production output for the fiscal year was ¥1,843 million, or 121.8% of the previous fiscal year, confirming a full-year recovery from the decline caused by production facility renovations in the previous fiscal year. - FY2020-Q3Recovery in productionAnnual report
「During the cumulative nine-month period, production in the Fine Chemicals segment increased significantly from the previous year. This was because production volume had declined in the previous fiscal year due to process stoppages associated with renovations to production facilities.」
Production in the Fine Chemicals segment increased significantly year on year as a reaction to process stoppages associated with production facility renovations in the previous fiscal year. Production was ¥1,366 million, or 127.0% of the same period of the previous year. - FY2019Annual results showing lower productionAnnual report
「Fine Chemicals segment 1,512 89.2」
Production in the Fine Chemicals segment was ¥1,512 million in the current fiscal year, or 89.2% of the previous fiscal year's level. This filing does not explicitly state a causal relationship with the production facility adjustments described in the previous quarter. - FY2019-Q1First statedAnnual report
「During the cumulative first-quarter period, production in the Fine Chemicals segment declined significantly. The main factor was production facility adjustments.」
Production in the Fine Chemicals segment declined significantly, with production facility adjustments cited as the main factor.